QALY gained

Related by string. * QALYs : per QALY gained . QALY / Gaining . gains . gainer . Gains . Gainer . gaining . GAIN . Gain . Gained . GAINS . GAINING . GAINED . GAiN : gaining steam . Gain insight . pared gains . Gain Loss . unrealized gains losses . percentage gainer . gaining momentum . gained . biggest gainer . Dollar Gains . Realized hedging gain . Unrealized gain . unrealized gain . Terrance Gainer outgoing * *

Related by context. Frequent words. (Click for all words.) 74 QALY 65 QALYs 56 HbA1C 54 morbidity mortality 53 biochemical recurrence 53 HbA 1c 53 creatinine clearance 53 % CI #.#-#.# [003] 51 CI -#.# 51 confidence interval #.#-#.# 51 glomerular filtration rate 51 mmol l 51 FOLFOX4 51 sensitivity specificity 51 pg mL 50 estimated glomerular filtration 50 p = .# [002] 50 HbA1c levels 49 anticoagulation therapy 49 androgen deprivation 49 chlorambucil 49 hemoglobin A1C 49 μg L 49 prevalences 49 thromboprophylaxis 49 tibolone 49 % CI #.#-#.# [007] 48 hemoglobin concentration 48 Secondary endpoints include 48 μg kg 48 pg ml 48 glycated hemoglobin 48 hemoglobin A1c 48 paclitaxel eluting stents 48 bendamustine 48 Secondary endpoints included 48 cubic millimeter 48 HRQOL 48 CI #.#-#.# [002] 48 DALYs 48 metabolic parameters 48 therapeutic regimens 48 nonoperative 48 inhaled nitric oxide 47 mL kg 47 microliter 47 hyperbilirubinemia 47 statistically significant p = 47 serum concentrations 47 NHANES III 47 serum PSA 47 Adjusted Diluted EPS 47 #.#per [002] 47 prespecified 47 % CI #.#-#.# [006] 47 noninferiority 47 lumiracoxib 47 confidence interval CI 47 bilirubin levels 47 RECIST criteria 47 nonobese 47 mortality morbidity 47 HRQoL 47 Consolidated adjusted EBITDA 46 beta blocker therapy 46 plus prednisone 46 platelet inhibition 46 dacarbazine 46 Secondary endpoints 46 ischemic cardiomyopathy 46 clinically meaningful improvement 46 Noninterest expense decreased 46 ACR# response 46 pramlintide 46 Fully diluted EPS 46 PER YEAR 46 chemoradiotherapy 46 highest quintile 46 cystectomy 46 annualized relapse 46 LDL lowering 46 fraction LVEF 46 rEEG 46 coronary revascularization 46 EPADS 46 prospectively defined 46 PSA velocity 46 antihypertensive agents 46 preoperatively 46 hypoglycemic events 46 comorbid conditions 46 univariate analysis 46 Constant Currency 46 serum calcium 45 XGEVA 45 ml min 45 #.#/unit [001] 45 tecarfarin 45 platelet reactivity 45 normotensive 45 daunorubicin

Back to home page